Professional Documents
Culture Documents
Laser Lecture
Laser Lecture
Photobiology
Cellular effects of phototherapy can be classified into primary (light-induced),
secondary (which occur in response to the primary effects) and tertiary effects
(Dyson, 2006).
Primary reactions are generally restricted to the absorption of photons while
secondary effects are not unique to phototherapy and, because their occurrence
depends on the sensitivity of the cells, are less predictable than primary effects
(Dyson, 2006). Tertiary effects are the least predictable since the response is
influenced by the internal and external environment and by intracellular interactions.
In primary responses:
1. photons emitted by the laser reach the mitochondria (Theralase, 2003) and
cell membranes of low lying cells (fibroblasts, keratinocytes or endothelial)
where the photonic energy is absorbed by chromophores (mitochondrial
cytochromes, porphyrins and flavoproteins) and is converted to chemical
kinetic energy (Matic et al, 2003) within the cell.
2. This causes changes in membrane permeability, improved signaling between
mitochondria, nucleus and cytosol and nitric oxide formation.
3. Increased oxidative metabolism to produce more ATP (Yu et al, 1997).
4. Normalization of cell function, pain relief and wound healing (Figure 1)
(Dyson, 2006)
Secondary reactions:
1. Various physiological changes at the cellular level such as changes in cell
membrane permeability (Figure 1) (Dyson, 2006).
2. Calcium is released from the mitochondria into the cytoplasm with changes in
intracellular calcium levels (Tunér and Hode, 2002) which:
Stimulates cell metabolism and the regulation of signaling pathways
responsible for significant events required for wound repair such as:
Cell migration
RNA and DNA synthesis
Cell mitosis
Protein secretion
Cell proliferation (Kiepeis et al, 2001).
Tertiary effects (Systemic effect):
1. Induced in cells at a distance from the cells in which the secondary events
occur (Dyson, 2006).
2. Irradiated or energized cells communicate with each other, and with non
irradiated cells, through increased levels of cytokines or growth factors
(Vladimirov, 2004) resulting in inter-cellular communication (Tunér and
Hode, 2002).
3. There is an increase in the immune response with the activation of T-
lymphocytes, macrophages and number of mast cells (Hamblin and Deidova,
2006).
4. An increase in the synthesis of endorphins and decrease in bradykinin results
in pain relief.
5. Certain molecules such as porphyrins can be converted into a long-lived triplet
state after photon absorption. This triplet state can interact with ground-state
oxygen with energy transfer leading to the production of a reactive singlet
oxygen species (Hamblin and Deidova, 2006).
6. Alteration of mitochondrial metabolism and activation of the respiratory chain
by illumination, which would also
7. Increase production of superoxide anions.
8. Reverse the inhibition of cytochrome c oxidase by nitric oxide (NO) and thus
increase the rate of respiration with consequently more ATP synthesis
(Hamblin and Deidova, 2006).
(Fig. 1) Cellular effects of phototherapy (Tunér and Hode, 2002).
Therapeutic applications:
1. Reduces pain in a large variety of acute and chronic pain entities including
pain related to abnormalities in nerves, soft tissue, muscles, tendons, joints and
bone.
2. Reduces swelling and inflammation associated with acute injuries in
superficial muscles, tendons, ligaments, bursa, and sheaths (Woodruff et al,
2004).
3. Improves wound healing of slow-to-healing or non healing wounds in soft
tissues, tendons and bone due to improved tissue oxygenation and nutrition
(Woodruff et al, 2004).
4. Improves absorption of interstitial fluid (anti edematous) and increases
lymphatic circulation and drainage which results in better tissue regeneration
(Takac and Stojanovic, 1998).
5. Improves local and systemic blood circulation which is useful in blood-related
conditions such as Buerger’s and Raynaud’s diseases and torpid leg ulcers.
6. Enhance autoimmune response in immune deficient conditions such as
psoriasis, rheumatoid arthritis and atopic dermatitis (Woodruff et al, 2004).
7. Controls hypertension by increasing flow rate and increasing the diameter of
the vessels (Gabel, 1995).
8. Restores normal pigment in abnormally colored cutaneous lesions.
9. Laser therapy also has benefits for patients with Bell’s palsy, psoriasis and
unhealed donor areas following skin grafting (Baxter et al, 1997).
Phototherapy for superficial wound healing:
1. Clearance of necrotic or slough tissue, reduced signs of infection, reduced
amount and odor of fluid in highly exuding wounds, reduced pain and
resumption of the immune response initiated by the inflammatory phase.
2. He-Ne laser (5 J/cm2 ) stimulates mitochondrial activity, which leads to
normalization of cell function and stimulates cell proliferation and migration
of wounded fibroblasts to accelerate wound closure (Hawkins and
Abrahamse, 2006).
3. Ga/As diode laser (3 J/cm2) (120 mw) stimulated fibroblast proliferation
without impairingprocollagen synthesis (Pereira et al., 2002).
4. For open wounds or ulcers, the laser probe is normally held 1-2cm from the
wound while the periphery is treated with the laser probe in direct contact. The
open area of the wound should receive a lower dose than the skin periphery
(Tunér and Hode, 2002).
5. In the treatment of a chronic ulcer for example, a higher dose such as 3-4
J/cm2 will be used on points along the periphery of the wound followed by a
lower dose of 0.5 J/cm2 over the open wound (Tunér and Hode, 2002).
6. Special precautions such as holding the probe close (non-contact) to the wound
and cleaning the probe with an alcohol wipe have to be used to reduce
contamination during laser treatment (Tunér and Hode, 2002).
7. Phototherapy using a wavelength of 630 nm (1-20 J/cm2) results in bacterial
inhibition which may be an important consideration when selecting the correct
wavelength for infected wounds (Nussbaum et al, 2003).
8. An infected ulcer can be treated twice weekly until the infection clears.
9. Patients on prescribed medication or who have conditions known to cause
photosensitivity reactions should also avoid LLLT.
10. It is unlikely that a combination of laser and drug will trigger a
photosensitivity response however patients should be patch tested with a small
dose and examined after 24-48 hours to determine if there is a hypersensitivity
reaction. (Lucas et al, 2003).
11. Acute wounds should be treated daily while chronic wounds should be treated
1-2 times a week.
12. Chronic tissue conditions require more treatment intervals where two or three
treatments a week are considered as the maximum.
13. As a general rule, it is better to use 3-4 treatments a week with moderate doses
than using higher doses and fewer treatments (Tunér and Hode, 2002).
Phototherapy for pain relief:
1. Laser therapy provides relief for musculoskeletal pain, post fracture pain, pain
at origin or insertion of any muscle or tendon, haematoma, and neurogenic
pain
2. Most acute musculoskeletal injuries should be treated daily over a short period
whereas chronic musculoskeletal injuries should be treated over a longer
period every week if palliative or every 2-3 days if there is low grade
inflammation (Tunér and Hode, 2002).
3. An infra-red probe has a penetration depth of several centimetres and is used
for musculoskeletal injuries, acupoints, neurogenic pain and trigger points
(Theralase, 2003).
4. The most frequently used laser for pain therapy is the Ga/AI/As diode that
emits coherent light in the near infrared waveband, usually 820-840 nm, and
with a continuous wave power output of 60 mW(Moore et al, 2002).
5. A near infrared (810 nm) laser probe can be used to treat pain while a cluster
probe can be used for soft tissue inflammation and pain trigger points (muscle,
tendon and ligaments).
6. Anti inflammatory by lowering, in a dose-dependent manner, levels
of prostaglandin E2 (PGE2), generated through the arachidonic acid pathway,
increases the sensitivity of nociceptors during inflammation; the counteracting
effects of LLLT therefore inhibit this sensitization(Ferreira et al., 2005).
7. LLLT produces dose‐dependent reduction, interleukin 1-beta, tumor necrosis
factor-alpha (acute inflammatory states), the cellular influx of neutrophil
granulocytes, oxidative stress, edema, and bleeding(Bjordal et al., 2006).
8. Laser suppressed nerve conduction in nociceptive fibers and caused a variety
of neurotransmitter effects such as increased serotonin, beta‐endorphin, and
acetylcholine esterase activity (Chow et al., 2007).
Precautions:
1. Patients should wear laser‐protective glasses. Laser beams, can similarly cause
ocular damage when reaching the retina (Teichman et al., 1999).
2. In addition, LLLT should take place in a controlled area with minimal access
to avoid inadvertent exposure to passersby.
3. One should remain vigilant about avoiding laser reflection from mirrored
surfaces.
Contraindications:
Absolute contraindications to LLLT the following three conditions: direct
treatment of the eye, cancer, hemorrhage, and a pregnant uterus.
Relative contraindications include treatment over open epiphyses, autonomic
ganglia, the heart, reproductive organs, infected tissue, photosensitive skin or
tissue, and in patients with impaired sensation or responsiveness.
(Fig.2) Key aspects of phototherapy that can be used to establish an effective therapeutic regimen
for the treatment of superficial wounds or skin conditions and musculoskeletal injuries
LOW LEVEL LASER THERAPY
Definition
Fig. 22Monochromaticity
3. Collimation
The laser beam is well collimated, that is, there is minimal divergence of the photons.
That means the photons move in a parallel fashion, thus concentrating a beam of
light.
On the other hand, white light is composed of many wavelengths (colors) that
superimpose their phases on one another and scatter in all direction (figure 23).
TYPES OF LASERS
Lasers are classified according to the nature of the material placed between two
reflecting surfaces. There are potentially thousands of different types of lasers, each
with specific wavelengths and unique characteristics, depending on the lasing
medium utilized. The lasing mediums used to create lasers include the following
categories:
1. Solid state lasers (Ruby or Crystal lasers): this consists of a small synthetic
ruby rod made of aluminum oxide and chromium.
2. Gas lasers: the helium neon (HeNe), argon, and carbon dioxide (CO 2).
3. Semiconductor or diode lasers: The gallium arsenide (GaAs) and gallium
aluminum arsenide (GaAlAs).
4. Liquid lasers: are also known as dye lasers because they use organic dyes as
the lasing medium.
5. Chemical lasers: are usually extremely high powered and frequently used for
military purposes.
Lasers can also be categorized as either high or low power, depending on the
intensity of energy they deliver. High-power lasers are also known as "hot" lasers
because of the thermal responses they generate. These are used in the medical realms
in numerous areas, including surgical cutting and coagulation, ophthalmologic,
dermatologic, oncologic, and vascular specialties.
The use of low-power lasers for wound healing and pain management is a
relatively new area of application in medicine. These lasers produce a maximal
output of less than 1 milli watt (1mW= 1/1000 W) work by causing photochemical,
rather than thermal, effects. No tissue warming occurs.
Penetration Depth
Laser light emitted in the near-infrared band penetrates
soft tissue deeper than light emitted in the visible
red band (see Fig. 11-6). Why is it so? As shown in
Table 11-4, the depth to which a laser beam of light can
penetrate soft tissues depends on two factors: absorption
and scattering. First, the greater the absorption of photons
by superficial tissues, the fewer the number of photons
the deeper tissues can absorb. In other words, penetration
depth (P) is inversely related to absorption (A), meaning
that the greater the absorption superficially, the lesser
the penetration depth (P = 1/A). Biophysics indicates that
visible red laser light is absorbed much more by superficial
tissues (skin and blood) than is infrared invisible light
(Nussbaum et al., 2003). Second, for any laser light to
physiologically and therapeutically affect tissues, it must
first be able to penetrate the skin and underlying targeted
soft tissue before being absorbed by the wavelengthspecific
chromophores buried in the layers of this tissue.
When a laser beam of light hits soft tissues, a significant
portion of its photons is scattered, or deflected, in various
directions away from the original direct path to the
targeted area. The biophysics of laser indicates that scattering
is inversely related to wavelength (S = 1/l). It is
greatest at short wavelengths and gradually decreases at
longer wavelengths (Houza et al., 1993; Nussbaum et al.,
2003). This means that photons of red lasers will experience more scattering than
those of infrared lasers when penetrating
soft tissues. Biophysics has also established that
penetration depth (P) is inversely related to scattering (S),
meaning that penetration depth decreases as scattering
increases (P = 1/S). As stated earlier, scattering is more
pronounced with shorter-wavelength lasers (red) than
with longer-wavelength lasers (infrared). Compared to
red light lasers, infrared light thus penetrates deeper into
soft tissues because it presents less superficial absorption
and scattering (see Table 11-4 and Fig. 11-6). Penetration
depth value is defined (Low et al., 1990; Baxter, 1994) as
the tissue depth, measured in centimeters, at which the
laser beam energy is reduced to 37% of its original value
(100%). This value is derived from the following formula:
Penetration depth value = 1/e, where e is a constant value
of 2.718. Penetration depth values for human tissues are
approximately less than 1 cm for red light lasers and less
than 5 cm for infrared light lasers.
REFERENCES
Baranowski AP, Curran NC. (2008); Pharmacological diagnostic tests. In:
Breivik H, Campbell W, Nicholas M, eds. Clinical Management of Pain—
Practice and Procedures, 2nd Edn. London: Arnold, 2008; Chapter 123 (in press)
Baxter G.D., Diamantopoulos C., O’Kane S. andShields S. (1997) Therapeutic
Lasers Theory and Practice, Churchill Livingstone, New York, N.Y.
Bjordal, J. M.; Johnson, M. I.; Iversen, V.; Aimbire, F.; Lopes-Martins, R.
A. B. (2006). "Low-Level Laser Therapy in Acute Pain: A Systematic Review of
Possible Mechanisms of Action and Clinical Effects in Randomized Placebo-
Controlled Trials". Photomedicine and Laser Surgery 24 (2): 158.
Bjordal, J. M.; Johnson, M. I.; Iversen, V.; Aimbire, F.; Lopes-Martins, R.
A. B. (2006). "Low-Level Laser Therapy in Acute Pain: A Systematic Review of
Possible Mechanisms of Action and Clinical Effects in Randomized Placebo-
Controlled Trials". Photomedicine and Laser Surgery 24 (2): 158.
Bogduk N. (2007); Diagnostic nerve blocks in chronic pain. In: Breivik H,
Shipley M, eds. Pain Best Practice and Research Compendium. London: Elsevier,
2007; 47–55
Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L,
Breivik Hals EK, Kvarstein G, and Stubhaug A. (2008); Assessment of pain.
British Journal of Anaesthesia 101 (1): 17–24
Breivik H, Collett B, Ventafridda V, Cohen R and Gallacher D. (2006);
Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment.
Eur J Pain; 10: 287–333
Chow RT, David MA, and Armati PJ. (2007); 830 nm laser irradiation induces
varicosity formation, reduces mitochondrial membrane potential and blocks fast
axonal flow in small and medium diameter rat dorsal root ganglion neurons:
implications for the analgesic effects of 830 nm laser. Journal of the Peripheral
Nervous System. 2007;12:28‐39.
Cleveland Clinic, Health information. (2008)"Psychogenic pain - definition
from Biology-Online.org" Biology-online.org. Retrieved 2008 -11-05.
Daut RL, Cleeland CS, Flanery RC. (1983);Development of the Wisconsin
Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983;
17: 197–210
Digby G et al (2009) Physiotherapy and cardiac rhythm devices: a review of the
current scope of practice. Europace; 11: 850-859.
Dubinsky, RM and Miyasaki, J. (2009). "Assessment: Efficacy of
transcutaneous electric nerve stimulation in the treatment of pain in neurologic
disorders (an evidence-based review): Report of the Therapeutics and Technology
Assessment Subcommittee of the American Academy of
Neurology". Neurology 74 (2): 173–176.
Dyson M. (2006) Primary, secondary and tertiary effects of phototherapy: a
review. Mechanisms of Low Level Light Therapy. Mechanisms for Low-Light
Therapy, edited by Michael R. Hamblin, Ronald W. Waynant, Juanita Anders,
Proceedings of SPIE Vol. 6140 (SPIE, Bellingham, WA, 2006) 6140, 614005-1
— 614005-12.
Ferreira DM, Zangaro RA, Villaverde AB, et al (2005). Analgesic effect of
He‐Ne (632.8 nm) low‐level laser therapy on acute inflammatory pain.
Photomedicine and Laser Surgery. 2005;23(2):177‐181.
Hamblin M.R., and Deidova, T.N. (2006) Mechanisms of Low Level Light
Therapy. Mechanisms for Low-Light Therapy, edited by Michael R. Hamblin,
Ronald W. Waynant, Juanita Anders, Proceedings of SPIE Vol. 6140 (SPIE,
Bellingham, WA, 2006) 614001-1- 614001-11.
Hawkins D., and Abrahamse H. (2006a) The role offluence in cell viability,
proliferation and membraneintegrity of wounded human skin fibroblasts
followinghelium-neon laser irradiation. Lasers in Surgery andMedicine. 38(1),
74-83.
Hicks CL, von Baeyer CL, Spafford PA, et al. (2001); The faces pain scale-
revised: toward a common metric in pediatric pain measurement. Pain 93: 173–83
International Association for the Study of Pain: Pain Definitions [Retrieved
10 Sep 2011]. Derived from Bonica JJ. The need of a taxonomy. Pain.
1979;6(3):247–8.
Johnson, MI (1998);The analgesic effects and clinical use ofacupuncture-like
TENS (AL-TENS). Physical TherapyReviews 3: 73–93.
Jørum E and Arendt-Nielsen L. (2008); Sensory testing and clinical
neurophysiology. In: Breivik H, Campbell W, Nicholas M, eds. Clinical
Management of Pain—Practice and Procedures, 2nd Edn. London: Arnold, 2008;
Chapter 122 (in press)
Khadilkar, A. Odebiyi, DO. Brosseau, L and Wells, GA. (2008).
"Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic
low-back pain". In Brosseau, Lucie. "Cochrane Database of Systematic
Reviews". The Cochrane database of systematic reviews (4): CD003008.
Kiepeis V.E., Cornell-Bell A. and Trinkaus-Randall V.(2001) Growth factors
but not gap junctions play a role in injury induced Ca2 waves in epithelial cells. J
Cell Sci.114(Pt23), 4185-4195.
Kooijman CM, Dijkstra PU, Geertzen JH, Elzinga A and van der Schans CP.
(2000); Phantom pain and phantom sensations in upper limb amputees: an
epidemiological study. Pain. 87(1):33–41.
Loeser JD, (2001);Bonica’s Management of Pain, 3rd ed. Philadelphia,
Lippincott Williams & Wilkins, 2001.
Lucas C., van Gemert M.J. and De Haan R.J. (2003) Efficacy of low level
laser therapy in the management of stage Ill decubitus ulcers: a prospective,
observer-blinded multicentre randomized clinical trial. Lasers Med Sci.18(2), 72-
77
Matic M., Lazetic B., Poljacki M., Duran V. and lvkov-Simic M. (2003) Low
level laser irradiation and its effects on repair processes in the skin. Med Pregl.
56(3-4), 137-141.
Melzack R and Katz J. (2006); Pain assessment in adult patients. In: McMahon
SB, Koltzenburg M, eds. Wall and Melzack’s Textbook of Pain, 5thEdn. London:
Elsevier, 2006; 291–304
Melzack R, Wall P (1965)The Challenge of Pain.London: Penguin Books.
Melzack, R, Vetere, P and Finch, L (1983); Transcutaneous electricalnerve
stimulation for low back pain. A comparison ofTENS and massage for pain and
range of motion. PhysicalTherapy 63: 489–493.
Moore P., Ridgeway T.D., Higbee R.G., Howard E.W.and Lucroy M.D.
(2002) Effect of wavelength on low intensity laser irradiation stimulated cell
proliferation in vitro. Lasers Surg Med. 36(1), 8-12.
Niv D, Kreitler S, Diego B and Lamberto A. (2007);"The Handbook of Chronic
Pain". Nova Biomedical Books; ISBN 1-60021-044-9.
Nussbaum E.L, Lilge, L., and Mazzulli, T. (2003) Effects of low-level laser
therapy (LLLT) of 810 nm upon in vitro growth of bacteria: relevance of
irradiance and radiant exposure. J Clin Laser Med Surg. 21(5), 283-90.
Pereira A.N., Eduardo Cde. P., Matson E. andMarques M.M. (2002) Effect of
low power laser irradiation on cell growth and procollagen synthesis of cultured
fibroblasts. Lasers Surg Med. 31(4), 263-267.
Scherder, E, Van Someren, E, Swaab, D (1999) Epilepsy: apossible
contraindication for transcutaneous electricalnerve stimulation. Journal of Pain
and Symptom Management17: 152–153
Sluka, K.A. and D. Walsh. (2003) Transcutaneous electrical nerve stimulation:
basic science mechanisms and clinical effectiveness. J Pain, 2003. 4(3): p. 109-
21.
Spanswick CC and Main CJ. (2000); Pain management: an interdisciplinary
approach. Edinburgh: Churchill Livingstone; ISBN 0-443-05683-8. p. 93.
Tafur, J. .; Mills, P. J. (2008). "Low-Intensity Light Therapy: Exploring the
Role of Redox Mechanisms". Photomedicine and Laser Surgery 26 (4): 323.
Takac and Stojanovic S. (1998) Diagnostic and biostimulating lasers. Med
Pregl. 51(5-6), 245-249.
Teichman JMH, Vassar GJ, Yates JT, Angle BN, et al. (1999); Color vision
deficits and laser eyewear protection for soft tissue laser applications. Journal of
Urology. 1999;161:874‐880.
Theralase (2003) Therapeutic laser treatment Laser Theory from designers and
manufacturers of therapeutic medical laser systems
Thienhaus O and Cole BE. (2002); Classification of pain. In: Weiner R. Pain
management: a practical guide for clinicians. Boca Raton: CRC Press; ISBN 0-
8493-0926-3. p. 28.
Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW,
Hansson P, Hughes R, Nurmikko T and Serra J. (2008); Neuropathic pain:
redefinition and a grading system for clinical and research purposes. Neurology.
70(18):1630-5.
Tunér J. and Hode L., (2002) Laser Therapy — Clinical Practice and Scientific
Background. Prima Books AB, Grangesberg, Sweden. Chapter 1. Some basic
laser physics. pp. 12, 21, 22, (ISBN: 91-631-1344-9).
Turk DC and Okifuji A. (2001); Pain terms and taxonomies of pain. In: Bonica
JJ, Loeser JD, Chapman CR, Turk DC, Butler SH. Bonica'smanagement of pain.
Hagerstwon, MD: Lippincott Williams & Wilkins; ISBN 0-683-30462-3.
Vladimirovlu. A., KlebanovG.l., Borisenko G.G. andOsipovA.N. (2004)
Molecular and cellular mechanism of the low intensity laser radiation effect.
Biofizika. 49(2), 339-350.
Walsh, D (ed) (1997c) TENS. Clinical Applications and Related Theory.
Churchill Livingstone, New York;
Wang XS, Cleeland CS. (2008); Outcomes measurement in cancer pain.In:
Wittink HM, Carr DB, eds. Pain Management: Evidence,Outcomes and Quality
of Life. A Sourcebook. London: Elsevier,2008; 361–76
Watson T (2008)Electrotherapy: Evidence-Based Practice. London: Churchill
Livingstone.
Wolff MS. (1989); Chronic Pain—Assessment of Physical Therapists’
Knowledge and Attitudes [thesis]. Boston: Massachusetts General Hospital
Institute of health professions.
Woodruff L., Bounkeo J., Brannon W., Dawes K.,Barham C., Waddell D.
and Enwemeka C. (2004) The efficacy of laser therapy in wound repair: A meta-
analysis of the literature. Photomedicine and Laser Surgery. 22(3), 241-247.
Woolf CJ. (2010).What is this thing called pain?. Journal of Clinical
Investigation. 120(11):3742–4.
Yu W., McGown M., Ippolito K. and Lanzafame R.J.(1997) Photostimulation
of oxidative metabolism and electron chain enzymes in rate liver mitochondria.
Photochem. Photobiol. 66, 866-871.